dc.contributor.author | Vladyka, Ondřej | |
dc.contributor.author | Vrabcová, Petra | |
dc.contributor.author | Reiterová, Michaela | |
dc.contributor.author | Paračková, Zuzana | |
dc.contributor.author | Haesler, Robert | |
dc.contributor.author | Šedivá, Anna | |
dc.contributor.author | Kalina, Tomáš | |
dc.contributor.author | Klocperk, Adam | |
dc.date.accessioned | 2023-12-04T11:10:41Z | |
dc.date.available | 2023-12-04T11:10:41Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14178/2095 | |
dc.description.abstract | The aim of this study was to investigate the impact of thymic dysplasia on the phenotypic and functional characteristics of T cells in patients with 22q11.2 deletion syndrome, including T-cell phenotype, transcriptional profile, cytokine production, as well as the possibility of utilizing IL-7 to recover their numbers and function. We found a strong bias towards Th1 response in pediatric and young adult 22q11.2DS patients, expansion of CXCR5(+) follicular helper cells and CXCR3(+)CCR6(-) Th1 cells, increased production of cytokines IFN-γ, IL-10, IL-2, IL-21 and TNF-α. This Th1 skew was primarily driven by expanded terminally differentiated T cells. IL-7 further reduced naive T cells, increased cytokine production and caused an upregulation of exhaustion markers. Thus, Th1 bias in T cell populations persists from infancy into adolescence and is accompanied by accelerated maturation of T cells into memory stages. This phenotype is exacerbated by IL-7 which causes further decrease in naïve T cells in vitro. | en |
dc.language.iso | en | |
dc.relation.url | https://doi.org/10.1016/j.clim.2023.109793 | |
dc.rights | Creative Commons Uveďte původ-Neužívejte dílo komerčně-Nezpracovávejte 4.0 International | cs |
dc.rights | Creative Commons Attribution-NonCommercial-NoDerivativeWorks 4.0 International | en |
dc.title | Th1/interferon-γ bias in 22q11.2 deletion syndrome is driven by memory T cells and exacerbated by IL-7 | en |
dcterms.accessRights | openAccess | |
dcterms.license | https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode | |
dc.date.updated | 2025-01-15T10:12:10Z | |
dc.subject.keyword | Exhaustion | en |
dc.subject.keyword | IFN-γ | en |
dc.subject.keyword | IL-7 | en |
dc.subject.keyword | Immunodeficiency | en |
dc.subject.keyword | RNA-seq | en |
dc.subject.keyword | Spectral cytometry | en |
dc.subject.keyword | thymus | en |
dc.identifier.eissn | 1521-7035 | |
dc.relation.fundingReference | info:eu-repo/grantAgreement/MSM//LX22NPO5102 | |
dc.relation.fundingReference | info:eu-repo/grantAgreement/MZ0/NU/NU20-05-00282 | |
dc.relation.fundingReference | info:eu-repo/grantAgreement/MZ0/NU/NU23-05-00097 | |
dc.relation.fundingReference | info:eu-repo/grantAgreement/FN/I-FN/I-FNM | |
dc.relation.fundingReference | info:eu-repo/grantAgreement/MZ0/NU/NU20-05-00282 | |
dc.date.embargoStartDate | 2025-01-15 | |
dc.type.obd | 73 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | |
dc.identifier.doi | 10.1016/j.clim.2023.109793 | |
dc.identifier.utWos | 001100663700001 | |
dc.identifier.eidScopus | 2-s2.0-85173948421 | |
dc.identifier.obd | 637779 | |
dc.identifier.riv | RIV/00216208:11130/23:10470118 | |
dc.identifier.pubmed | 37776967 | |
dc.subject.rivPrimary | 30000::30100::30102 | |
dcterms.isPartOf.name | Clinical Immunology | |
dcterms.isPartOf.issn | 1521-6616 | |
dcterms.isPartOf.journalYear | 2023 | |
dcterms.isPartOf.journalVolume | 256 | |
dcterms.isPartOf.journalIssue | November | |
uk.faculty.primaryId | 109 | |
uk.faculty.primaryName | 2. lékařská fakulta | cs |
uk.faculty.primaryName | Second Faculty of Medicine | en |
uk.faculty.secondaryId | 52 | |
uk.faculty.secondaryName | Fakultní nemocnice v Motole | cs |
uk.faculty.secondaryName | Motol University Hospital | en |
uk.department.primaryId | 109 | |
uk.department.primaryName | 2. lékařská fakulta | cs |
uk.department.primaryName | Second Faculty of Medicine | en |
uk.department.secondaryId | 1675 | |
uk.department.secondaryId | 100010693871 | |
uk.department.secondaryId | 1695 | |
uk.department.secondaryId | 100010692507 | |
uk.department.secondaryName | Klinika dětské hematologie a onkologie | cs |
uk.department.secondaryName | Klinika dětské hematologie a onkologie | en |
uk.department.secondaryName | Ústav imunologie 2. LF UK a FN Motol | cs |
uk.department.secondaryName | Department of Immunology, 2nd Faculty of Medicine and Motol University Hospital | en |
uk.department.secondaryName | Ústav imunologie | cs |
uk.department.secondaryName | Ústav imunologie | en |
uk.department.secondaryName | Klinika dětské hematologie a onkologie 2. LF UK a FN Motol | cs |
uk.department.secondaryName | Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine and Motol University Hos | en |
dc.type.obdHierarchyCs | ČLÁNEK V ČASOPISU::článek v časopisu::původní článek | cs |
dc.type.obdHierarchyEn | JOURNAL ARTICLE::journal article::original article | en |
dc.type.obdHierarchyCode | 73::152::206 | en |
uk.displayTitle | Th1/interferon-γ bias in 22q11.2 deletion syndrome is driven by memory T cells and exacerbated by IL-7 | en |